Reliability of prognostic factors in breast carcinoma determined by core needle biopsy

Japanese Journal of Clinical Oncology

Volumn 37, Issue 4, 2007, Pages 250-255

  Usami, Shin ^a   Moriya, Takuya ^a   Amari, Masakazu ^a   Suzuki, Akihiko ^a   Ishida, Takanori ^a   Sasano, Hironobu ^a   Ohuchi, Noriaki ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Breast cancer; Core needle biopsy; HER2; Hormone receptor; Prognostic factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ACCURACY; ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PROGNOSIS; RELIABILITY; SCORING SYSTEM; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 34447642377     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hym021     Document Type: Article

References (23)

1. Elvecrog EL, Lechner MC, Nelson MT. Nonpalpable breast lesions. Correlation of stereotaxic large-core needle biopsy and surgical biopsy results. Radiol 1993;188:453-55.
2. Parker SH, Burbank F, Jackman RJ, Aucreman CJ, Cardenosa G, Cink TM, et al. Percutaneous large-core breast biopsy. A multi-institutional study. Radiol 1994;193:359-64.
3. Nguyen M, McCombs MM, Ghandehari S, Kim A, Wang H, Barsky SH, et al. An update on core needle biopsy for radiologically detected breast lesions. Cancer 1996;78:2340-5.
4. Fajardo LL, Pisano ED, Caudry DJ, Gatsonis CA, Berg WA, Connolly J, et al. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions. Results of the Radiologic Diagnostic Oncology Group V study. Acad Radiol 2004;11:293-308.
5. Brenner RJ, Bassett LW, Fajardo LL, Dershaw DD, Evans WP, III, Hunt R, et al. Stereotactic core-needle breast biopsy: A multi-institutional prospective trial. Radiol 2001;218:866-72.
6. Verkooijen HM, and Core Biopsy After Radiological Localisation (COBRA) Study Group. Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease. Results of a multicenter prospective study with 95% surgical confirmation. Int J Cancer 2002;99:853-9.
7. Lower EE, Glass EL, Bradley DA, Blau R, Heffelfinger S. Impact of metastatic estrogen receptor and progesterone receptor status on survival. Breast Cancer Res Treat 2005;90:65-70.
8. Yang M, Moriya T, Oguma M, De La Cruz C, Endoh M, Ishida T, et al. Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases. Pathol Int 2003;53:422-8.
9. Bimer P, Oberhuber G, Stain J, Reithofer C, Samonigg H, Hausmaninger H, et al. Austrian Breast & Colorectal Cancer Study Group. Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. Clin Cancer Res 2001;7:1669-75.
10. Tavassoli FA, Devilee P, editors. World Health Organization Classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press 2003, 9-112.
11. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
12. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998;11:155-68.
13. Nath ME, Robinson TM, Tobon H, Chough DM, Sumkin JH. Automated large-core needle biopsy of surgically removed breast lesions: comparison of samples obtained with 14-, 16-, and 18-gauge needles. Radiol 1995;197:739-42.
14. Brem RF, Schoonjans JM, Goodman SN, Nolten A, Askin FB, Gatewood OM. Nonpalpable breast cancer: Percutaneous diagnosis with 11- and 8-gauge stereotactic vacuum-assisted biopsy devices. Radiol 2001;219:793-96.
15. Brem RF, Schoonjans JM, Sanow L, Gatewood OM. Reliability of histologic diagnosis of breast cancer with stereotactic vacuum-assisted biopsy. Am Surg 2001;67:388-92.
16. Andrade VP, Gobbi H. Accuracy of typing and grading invasive mammary carcinomas on core needle biopsy compared with the excisional specimen. Virchows Arch 2004;445:597-602.
17. Sharifi S, Peterson MK, Baum JK, Raza S, Schnitt SJ. Assessment of pathologic prognostic factors in breast core needle biopsies. Mod Pathol 1999;12:941-5.
18. Harris GC, Denley HE, Pinder SE, Lee AH, Ellis IO, Elston CW, et al. Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma. Am J Surg Pathol 2003;27:11-15.
19. Monticciolo DL. Histologic grading at breast core needle biopsy: comparison with results from the excised breast specimen. Breast J 2005;1:9-14.
20. Badoual C, Maruani A, Ghorra C, Lebas P, Avigdor S, Michenet P. Pathological prognostic factors of invasive breast carcinoma in ultrasound-guided large core biopsies. A correlation with subsequent surgical excisions. Breast 2005;14:22-7.
21. Zidan A, Christie Brown JS, Peston D, Shousha S. Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma. J Clin Pathol 1997;50:27-9.
22. Connor CS, Tawfik OW, Joyce AJ, Davis MK, Mayo MS, Jewell WR. A comparison of prognostic tumor markers obtained on image-guided breast biopsies and final surgical specimens. Am J Surg 2002;184:322-4.
23. Douglas-Jones AG, Collett N, Morgan JM, Jasani B. Comparison of core oestrogen receptor (ER) assay with excised tumour: Intratumoral distribution of ER in breast carcinoma. J Clin Pathol 2001;54:951-5.